Home >> Life Sciences >> Pharmaceuticals

EMEA (Europe, Middle East and Africa) Guaifenesin (API) Market 2017 Forecast to 2022

Published: Jan-2018 | Format: PDF | Global Info Research | Number of pages: 120 | Code: MRS - 201094

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.


Scope of the Report:
This report focuses on the Guaifenesin (API) in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
    Granules
    Synthokem Labs
    Haizhou Pharma
    Yuan Cheng Group
    Stellar Chemical
    Biesterfeld
    Seven Star Pharma
    Camlin Fine Science
    Gennex Lab
    Iwaki Seiyaku
    Pan Drugs
    Delta Synthetic
    Smart Pharm

Market Segment by Regions, regional analysis covers
Europe (Germany, France, UK, Russia, Italy and Turkey)
Middle East (Saudi Arabia, Israel, UAE and Iran)
Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers
    98%-99%
    >99%

Market Segment by Applications, can be divided into
    Pharmaceuticals
    Others

There are 13 Chapters to deeply display the EMEA Guaifenesin (API) market.

Chapter 1, to describe Guaifenesin (API) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Guaifenesin (API), with sales, revenue, and price of Guaifenesin (API), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Guaifenesin (API), for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Guaifenesin (API) market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Guaifenesin (API) research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source
Table of Contents
1 Market Overview
    1.1 Guaifenesin (API) Introduction
    1.2 Market Analysis by Type
        1.2.1 98%-99%
        1.2.2 >99%
    1.3 Market Analysis by Applications
        1.3.1 Pharmaceuticals
        1.3.2 Others
    1.4 Market Analysis by Regions
        1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
            1.4.1.1 Germany Market States and Outlook (2012-2022)
            1.4.1.2 France Market States and Outlook (2012-2022)
            1.4.1.3 UK Market States and Outlook (2012-2022)
            1.4.1.4 Italy Market States and Outlook (2012-2022)
            1.4.1.5 Russia Market States and Outlook (2012-2022)
            1.4.1.6 Turkey Market States and Outlook (2012-2022)
        1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
            1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
            1.4.2.2 UAE Market States and Outlook (2012-2022)
            1.4.2.3 Israel Market States and Outlook (2012-2022)
            1.4.2.4 Iran Market States and Outlook (2012-2022)
        1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
            1.4.3.1 South Africa Market States and Outlook (2012-2022)
            1.4.3.2 Nigeria Market States and Outlook (2012-2022)
            1.4.3.3 Egypt Market States and Outlook (2012-2022)
            1.4.3.4 Algeria Market States and Outlook (2012-2022)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Granules
        2.1.1 Business Overview
        2.1.2 Guaifenesin (API) Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 Granules Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2 Synthokem Labs
        2.2.1 Business Overview
        2.2.2 Guaifenesin (API) Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 Synthokem Labs Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3 Haizhou Pharma
        2.3.1 Business Overview
        2.3.2 Guaifenesin (API) Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 Haizhou Pharma Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4 Yuan Cheng Group
        2.4.1 Business Overview
        2.4.2 Guaifenesin (API) Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 Yuan Cheng Group Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5 Stellar Chemical
        2.5.1 Business Overview
        2.5.2 Guaifenesin (API) Type and Applications
            2.5.2.1 Type 1
            2.5.2.2 Type 2
        2.5.3 Stellar Chemical Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6 Biesterfeld
        2.6.1 Business Overview
        2.6.2 Guaifenesin (API) Type and Applications
            2.6.2.1 Type 1
            2.6.2.2 Type 2
        2.6.3 Biesterfeld Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7 Seven Star Pharma
        2.7.1 Business Overview
        2.7.2 Guaifenesin (API) Type and Applications
            2.7.2.1 Type 1
            2.7.2.2 Type 2
        2.7.3 Seven Star Pharma Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8 Camlin Fine Science
        2.8.1 Business Overview
        2.8.2 Guaifenesin (API) Type and Applications
            2.8.2.1 Type 1
            2.8.2.2 Type 2
        2.8.3 Camlin Fine Science Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9 Gennex Lab
        2.9.1 Business Overview
        2.9.2 Guaifenesin (API) Type and Applications
            2.9.2.1 Type 1
            2.9.2.2 Type 2
        2.9.3 Gennex Lab Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10 Iwaki Seiyaku
        2.10.1 Business Overview
        2.10.2 Guaifenesin (API) Type and Applications
            2.10.2.1 Type 1
            2.10.2.2 Type 2
        2.10.3 Iwaki Seiyaku Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.11 Pan Drugs
        2.11.1 Business Overview
        2.11.2 Guaifenesin (API) Type and Applications
            2.11.2.1 Type 1
            2.11.2.2 Type 2
        2.11.3 Pan Drugs Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.12 Delta Synthetic
        2.12.1 Business Overview
        2.12.2 Guaifenesin (API) Type and Applications
            2.12.2.1 Type 1
            2.12.2.2 Type 2
        2.12.3 Delta Synthetic Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.13 Smart Pharm
        2.13.1 Business Overview
        2.13.2 Guaifenesin (API) Type and Applications
            2.13.2.1 Type 1
            2.13.2.2 Type 2
        2.13.3 Smart Pharm Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 EMEA Guaifenesin (API) Market Competition, by Manufacturer
    3.1 EMEA Guaifenesin (API) Sales and Market Share by Manufacturer
    3.2 EMEA Guaifenesin (API) Revenue and Market Share by Manufacturer
    3.3 EMEA Guaifenesin (API) Price by Manufacturer (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Guaifenesin (API) Manufacturer Market Share
        3.4.2 Top 5 Guaifenesin (API) Manufacturer Market Share
    3.5 Market Competition Trend
4 EMEA Guaifenesin (API) Market Analysis by Regions
    4.1 EMEA Guaifenesin (API) Sales, Revenue and Market Share by Regions
        4.1.1 EMEA Guaifenesin (API) Sales by Regions (2012-2017)
        4.1.2 EMEA Guaifenesin (API) Revenue by Regions (2012-2017)
    4.2 Europe Guaifenesin (API) Sales and Growth (2012-2017)
    4.3 Middle East Guaifenesin (API) Sales and Growth (2012-2017)
    4.4 Africa Guaifenesin (API) Sales and Growth (2012-2017)
5 Europe Guaifenesin (API) by Countries, Type, Application and Manufacturers
    5.1 Europe Guaifenesin (API) Sales, Revenue and Market Share by Countries
        5.1.1 Europe Guaifenesin (API) Sales by Countries (2012-2017)
        5.1.2 Europe Guaifenesin (API) Revenue by Countries (2012-2017)
        5.1.3 Germany Guaifenesin (API) Sales and Growth (2012-2017)
        5.1.4 France Guaifenesin (API) Sales and Growth (2012-2017)
        5.1.5 UK Guaifenesin (API) Sales and Growth (2012-2017)
        5.1.6 Russia Guaifenesin (API) Sales and Growth (2012-2017)
        5.1.7 Italy Guaifenesin (API) Sales and Growth (2012-2017)
        5.1.8 Turkey Guaifenesin (API) Sales and Growth (2012-2017)
    5.2 Europe Guaifenesin (API) Sales and Revenue (value) by Manufacturers (2016-2017)
        5.2.1 Europe Guaifenesin (API) Sales by Manufacturers (2016-2017)
        5.2.2 Europe Guaifenesin (API) Revenue by Manufacturers (2016-2017)
    5.3 Europe Guaifenesin (API) Sales by Type (2012-2017)
    5.4 Europe Guaifenesin (API) Sales by Application (2012-2017)
6 Middle East Guaifenesin (API) by Countries, Type, Application and Manufacturers
    6.1 Middle East Guaifenesin (API) Sales, Revenue and Market Share by Countries
        6.1.1 Middle East Guaifenesin (API) Sales by Countries (2012-2017)
        6.1.2 Middle East Guaifenesin (API) Revenue by Countries (2012-2017)
        6.1.3 Saudi Arabia Guaifenesin (API) Sales and Growth (2012-2017)
        6.1.4 Israel Guaifenesin (API) Sales and Growth (2012-2017)
        6.1.5 UAE Guaifenesin (API) Sales and Growth (2012-2017)
        6.1.6 Iran Guaifenesin (API) Sales and Growth (2012-2017)
    6.2 Middle East Guaifenesin (API) Sales and Revenue (value) by Manufacturers (2016-2017)
        6.2.1 Middle East Guaifenesin (API) Sales by Manufacturers (2016-2017)
        6.2.2 Middle East Guaifenesin (API) Revenue by Manufacturers (2016-2017)
    6.3 Middle East Guaifenesin (API) Sales by Type (2012-2017)
    6.4 Middle East Guaifenesin (API) Sales by Application (2012-2017)
7 Africa Guaifenesin (API) by Countries, Type, Application and Manufacturers
    7.1 Africa Guaifenesin (API) Sales, Revenue and Market Share by Countries
        7.1.1 Africa Guaifenesin (API) Sales by Countries (2012-2017)
        7.1.2 Africa Guaifenesin (API) Revenue by Countries (2012-2017)
        7.1.3 South Africa Guaifenesin (API) Sales and Growth (2012-2017)
        7.1.4 Nigeria Guaifenesin (API) Sales and Growth (2012-2017)
        7.1.5 Egypt Guaifenesin (API) Sales and Growth (2012-2017)
        7.1.6 Algeria Guaifenesin (API) Sales and Growth (2012-2017)
    7.2 Middle East Guaifenesin (API) Sales and Revenue (value) by Manufacturers (2016-2017)
        7.2.1 Middle East Guaifenesin (API) Sales by Manufacturers (2016-2017)
        7.2.2 Middle East Guaifenesin (API) Revenue by Manufacturers (2016-2017)
    7.3 Middle East Guaifenesin (API) Sales by Type (2012-2017)
    7.4 Middle East Guaifenesin (API) Sales by Application (2012-2017)
8 EMEA Guaifenesin (API) Market Segment by Type
    8.1 EMEA Guaifenesin (API) Sales, Revenue and Market Share by Type (2012-2017)
        8.1.1 EMEA Guaifenesin (API) Sales and Market Share by Type (2012-2017)
        8.1.2 EMEA Guaifenesin (API) Revenue and Market Share by Type (2012-2017)
    8.2 98%-99% Sales Growth and Price
        10.2.1 EMEA 98%-99% Sales Growth (2012-2017)
        10.2.2 EMEA 98%-99% Price (2012-2017)
    8.3 >99% Sales Growth and Price
        10.3.1 EMEA >99% Sales Growth (2012-2017)
        10.3.2 EMEA >99% Price (2012-2017)
9 EMEA Guaifenesin (API) Market Segment by Application
    9.1 EMEA Guaifenesin (API) Sales Market Share by Application (2012-2017)
    9.2 Pharmaceuticals Sales Growth (2012-2017)
    9.3 Others Sales Growth (2012-2017)
10 EMEA Guaifenesin (API) Market Forecast (2017-2022)
    10.1 EMEA Guaifenesin (API) Sales, Revenue and Growth Rate (2017-2022)
    10.2 Guaifenesin (API) Market Forecast by Regions (2017-2022)
        10.2.1 Europe Guaifenesin (API) Market Forecast by Regions (2017-2022)
            10.2.1.1 Germany Guaifenesin (API) Sales Forecast 2017-2022
            10.2.1.2 France Guaifenesin (API) Sales Forecast 2017-2022
            10.2.1.3 UK Guaifenesin (API) Sales Forecast 2017-2022
            10.2.1.4 Russia Guaifenesin (API) Sales Forecast 2017-2022
            10.2.1.5 Italy Guaifenesin (API) Sales Forecast 2017-2022
            10.2.1.6 Turkey Guaifenesin (API) Sales Forecast 2017-2022
        10.2.2 Middle East Market Forecast by Regions (2017-2022)
            10.2.2.1 Saudi Arabia Guaifenesin (API) Sales Forecast 2017-2022
            10.2.2.2 Israel Guaifenesin (API) Sales Forecast 2017-2022
            10.2.2.3 UAE Guaifenesin (API) Sales Forecast 2017-2022
            10.2.2.4 Iran Guaifenesin (API) Sales Forecast 2017-2022
        10.2.3 Africa Market Forecast by Regions (2017-2022)
            10.2.3.1 South Africa Guaifenesin (API) Sales Forecast 2017-2022
            10.2.3.2 Nigeria Guaifenesin (API) Sales Forecast 2017-2022
            10.2.3.3 Egypt Guaifenesin (API) Sales Forecast 2017-2022
            10.2.3.4 Algeria Guaifenesin (API) Sales Forecast 2017-2022
    10.3 Guaifenesin (API) Market Forecast by Type (2017-2022)
    10.4 Guaifenesin (API) Market Forecast by Application (2017-2022)
11 Sales Channel, Distributors, Traders and Dealers
    11.1 Sales Channel
        11.1.1 Direct Marketing
        11.1.2 Indirect Marketing
        11.1.3 Marketing Channel Future Trend
    11.2 Distributors, Traders and Dealers
12 Research Findings and Conclusion
13 Appendix
    13.1 Methodology
    13.2 Analyst Introduction
    13.3 Data Source

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

EMEA (Europe, Middle East and Africa) Vegetable Capsules Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 124 | Code : MRS-214954 | 4480

Pill is a common part of many people’s lives for pharmaceutical use or as health Supplements, It has two main forms of tablets and capsules. Tablets were the most popular way to take medicine for quite some time. While since some characters such as hard to swallow and slice, too many additives and so on, most people tend to switch to capsules from the industrialization era on when capsule shells technologies and filling machines have been developed. Scope of the Report: This report fo Read more

EMEA (Europe, Middle East and Africa) Sugar Sphere Market Professional Survey Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 121 | Code : MRS-214864 | 4480

Sugar spheres are a widely used excipient for sustained-release pellet formulations. Sugar spheres (also called neutral pellets, nonpareil seeds, microgranules or sugar beads) are produced, preferably using a layered sugar-coating structure. The result is sugar spheres with sufficient mechanical stability for further processing. Scope of the Report: This report focuses on the Sugar Sphere Market Professional Survey in EMEA market, covering Europe, Middle East and Africa, This report c Read more

Global Active Pharmaceutical Ingredients Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 103 | Code : MRS-214050 | 3480

This report studies the Active Pharmaceutical Ingredients market. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical sub Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Gene Synthesis Market 2018 Forecast to 2023

Feb-2018 | Global Info Research | Pages : 105 | Code : MRS-214049 | 4880

Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built. Sco Read more

Global Botox Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Feb-2018 | Global Info Research | Pages : 108 | Code : MRS-214048 | 3480

Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined due to its stable property that Botox is used widely in Experimental Research and Clinical Application at the early stage. Scope of the Report: This report focuses on the Botox in global market, especia Read more

Global Pharmaceutical Hot Melt Extruder Market Research Report by Product Type, Application, Regions and Outlook 2017-2023

Jan-2018 | HeyReport | Pages : 77 | Code : MRS-213925 | 2030

Summary The global Pharmaceutical Hot Melt Extruder market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as follows: Read more

2018-2023 United States Neurofeedback System Market Report (Status and Outlook)

Feb-2018 | LPI (LP Information) | Pages : 89 | Code : MRS-213213 | 3360

In 2017, the Neurofeedback System market size was xx million in United States, and it will be xx million in 2023, with a CAGR of xx% between 2017 and 2023. In United States market, the top players include BrainMaster Technologies BEE Medic Brainquiry Mitsar Thought Technology Mind Media Wearable Sensing Split by product types/category, covering Slow Cortical Potential Neurofeedback (SCP-NF) Low-energy Neurofeedback System (LENS) Hemo Read more

2018-2023 UK Neurofeedback System Market Report (Status and Outlook)

Feb-2018 | LPI (LP Information) | Pages : 89 | Code : MRS-213212 | 3360

In 2017, the Neurofeedback System market size was xx million in UK, and it will be xx million in 2023, with a CAGR of xx% between 2017 and 2023. In UK market, the top players include BrainMaster Technologies BEE Medic Brainquiry Mitsar Thought Technology Mind Media Wearable Sensing Split by product types/category, covering Slow Cortical Potential Neurofeedback (SCP-NF) Low-energy Neurofeedback System (LENS) Hemoencephalographic (HEG) Read more

2018-2023 Philippines Neurofeedback System Market Report (Status and Outlook)

Feb-2018 | LPI (LP Information) | Pages : 89 | Code : MRS-213211 | 3360

In 2017, the Neurofeedback System market size was xx million in Philippines, and it will be xx million in 2023, with a CAGR of xx% between 2017 and 2023. In Philippines market, the top players include BrainMaster Technologies BEE Medic Brainquiry Mitsar Thought Technology Mind Media Wearable Sensing Split by product types/category, covering Slow Cortical Potential Neurofeedback (SCP-NF) Low-energy Neurofeedback System (LENS) Hemoence Read more

2018-2023 Malaysia Neurofeedback System Market Report (Status and Outlook)

Feb-2018 | LPI (LP Information) | Pages : 89 | Code : MRS-213210 | 3360

In 2017, the Neurofeedback System market size was xx million in Malaysia, and it will be xx million in 2023, with a CAGR of xx% between 2017 and 2023. In Malaysia market, the top players include BrainMaster Technologies BEE Medic Brainquiry Mitsar Thought Technology Mind Media Wearable Sensing Split by product types/category, covering Slow Cortical Potential Neurofeedback (SCP-NF) Low-energy Neurofeedback System (LENS) Hemoencephalog Read more

  • Payment Mode
Single User | $(USD)4480 View Pricing